Independent biomedical research group

From therapeutic concept to computational validation

We propose candidate therapeutic strategies and test them in silico using mechanistic modeling, scenario comparison, sensitivity analysis, and robustness checks. We then publish the results as research outputs designed for scientific scrutiny and reuse.

See workflow Browse publications Oncology • Immunology • Neurology
Scroll for details

Who we are

We are an independent research group working in computational and mechanistic biomedical research. Our focus is to generate candidate therapeutic strategies, evaluate them in silico, and publish results in a form that is clear, testable, and reviewable.

Independent • Mechanistic • In silico

Research philosophy

Mechanisms first: assumptions are explicit, and predictions are stated in measurable terms.

Evidence standard

Scenario comparison and robustness checks to keep conclusions stable under alternative assumptions.

Scientific communication

We aim for publication-grade clarity: what the model supports, what it doesn't, and why.

Mission

Develop candidate treatment strategies, validate them in silico, and publish research that can be scrutinized and built upon.

Strategy → Evidence → Publication

Candidate therapeutic strategies

We propose intervention ideas grounded in mechanistic reasoning and tractable experimental signatures.

Computational validation

We stress-test strategies with scenario comparison, sensitivity analysis, and robustness checks.

Peer-reviewed reporting

We publish in journals and maintain research records with transparent limitations and uncertainty.

Workflow

A practical pipeline from mechanism to in silico evidence-built to make conclusions durable and publishable.

Robust by design

1) Mechanistic framing

Define assumptions, constraints, and measurable predictions.

2) In silico evaluation

Compare scenarios, quantify sensitivity, and run robustness checks.

3) Publication

Report evidence boundaries clearly and link research records where appropriate.

In silico model visual

Focus areas

We propose candidate treatment strategies and evaluate them in silico across major biomedical domains.

Domains

Oncology

Therapeutic strategies derived from tumor and microenvironment mechanisms, tested in silico and published.

Immunology

Immune-modulation strategies evaluated computationally under competing scenarios and uncertainty.

Neurology

Systems-level therapeutic concepts assessed in silico with emphasis on constraints and testable predictions.

Research visual 1
Research visual 2
Research visual 3

Publications

The complete list of publications and research outputs is maintained on Zenodo (persistent records and DOIs where available).

Zenodo

FAQ

Quick answers for readers and reviewers.

FAQ
What do you do?
We propose candidate therapeutic strategies and evaluate them in silico using mechanistic modeling, scenario comparison, sensitivity analysis, and robustness checks, then publish results in scientific journals and research records.
Do you provide medical advice?
No. This website presents research content and does not provide medical advice, diagnosis, or patient-specific treatment recommendations.
Which domains do you focus on?
Oncology, immunology, and neurology.

Team

Core contributors and affiliations.

ORCID

Murad Novruzov

Role: Research Group Leader.

Affiliations:
1) Murad Novruzov Biomedical Research (Baku, Azerbaijan);
2) Azerbaijan Science and Health Initiatives (ASHI) (Baku, Azerbaijan).

Marziyya Mammadova, MD

Role: Clinical Expertise - clinical framing and translational insights.

Affiliations:
1) Azerbaijan State Advanced Training Institute for Doctors named after Aziz Aliyev;
2) Azerbaijan Science and Health Initiatives (ASHI).

Keval Raval, PhD

Role: In Silico Modelling - computational workflows and optimisation.

Affiliation:
Ramanbhai Patel College of Pharmacy, CHARUSAT University (Anand, India).

Waseem Ullah Khan, PhD

Role: Biological Systems - biological grounding and model validation.

Affiliation:
National Institute of Health (Islamabad, Pakistan).

Inam Ullah Khan, PhD

Role: Biological Systems - biological grounding and model validation.

Affiliation:
Islamic International Medical College, Riphah International University (Islamabad, Pakistan).

Ulkar Shiraliyeva, PhD candidate

Role: Chemistry Integration - chemical expertise for molecular-level accuracy.

Affiliation:
Azerbaijan State Oil and Industry University (Baku, Azerbaijan).

Scientific correspondence For publication-related questions and scientific discussion, contact us by email. This website presents research content and does not provide medical advice.

Partners

Organizations supporting our research mission.

Collaboration
Azerbaijan Health & Science Initiatives logo

Azerbaijan Health & Science Initiatives

Supporting biomedical research and scientific collaboration in Azerbaijan.